88 related articles for article (PubMed ID: 23041758)
1. Valproic acid induces the glutamate transporter excitatory amino acid transporter-3 in human oligodendroglioma cells.
Bianchi MG; Franchi-Gazzola R; Reia L; Allegri M; Uggeri J; Chiu M; Sala R; Bussolati O
Neuroscience; 2012 Dec; 227():260-70. PubMed ID: 23041758
[TBL] [Abstract][Full Text] [Related]
2. C6 glioma cells differentiated by retinoic acid overexpress the glutamate transporter excitatory amino acid carrier 1 (EAAC1).
Bianchi MG; Gazzola GC; Tognazzi L; Bussolati O
Neuroscience; 2008 Feb; 151(4):1042-52. PubMed ID: 18207650
[TBL] [Abstract][Full Text] [Related]
3. Loss of glial fibrillary acidic protein results in decreased glutamate transport and inhibition of PKA-induced EAAT2 cell surface trafficking.
Hughes EG; Maguire JL; McMinn MT; Scholz RE; Sutherland ML
Brain Res Mol Brain Res; 2004 May; 124(2):114-23. PubMed ID: 15135219
[TBL] [Abstract][Full Text] [Related]
4. 17β-Estradiol attenuates the activity of the glutamate transporter type 3 expressed in Xenopus oocytes.
Na HS; Park HP; Kim CS; Do SH; Zuo Z; Kim CS
Eur J Pharmacol; 2012 Feb; 676(1-3):20-5. PubMed ID: 22173127
[TBL] [Abstract][Full Text] [Related]
5. Carbamazepine enhances the activity of glutamate transporter type 3 via phosphatidylinositol 3-kinase.
Lee G; Huang Y; Washington JM; Briggs NW; Zuo Z
Epilepsy Res; 2005; 66(1-3):145-53. PubMed ID: 16150575
[TBL] [Abstract][Full Text] [Related]
6. Isoflurane induces a protein kinase C alpha-dependent increase in cell-surface protein level and activity of glutamate transporter type 3.
Huang Y; Zuo Z
Mol Pharmacol; 2005 May; 67(5):1522-33. PubMed ID: 15709112
[TBL] [Abstract][Full Text] [Related]
7. Glutamate transporter expression and function in human glial progenitors.
Maragakis NJ; Dietrich J; Wong V; Xue H; Mayer-Proschel M; Rao MS; Rothstein JD
Glia; 2004 Jan; 45(2):133-43. PubMed ID: 14730707
[TBL] [Abstract][Full Text] [Related]
8. The glutamate transport inhibitor DL-Threo-β-Benzyloxyaspartic acid (DL-TBOA) differentially affects SN38- and oxaliplatin-induced death of drug-resistant colorectal cancer cells.
Pedraz-Cuesta E; Christensen S; Jensen AA; Jensen NF; Bunch L; Romer MU; Brünner N; Stenvang J; Pedersen SF
BMC Cancer; 2015 May; 15():411. PubMed ID: 25981639
[TBL] [Abstract][Full Text] [Related]
9. The density of EAAC1 (EAAT3) glutamate transporters expressed by neurons in the mammalian CNS.
Holmseth S; Dehnes Y; Huang YH; Follin-Arbelet VV; Grutle NJ; Mylonakou MN; Plachez C; Zhou Y; Furness DN; Bergles DE; Lehre KP; Danbolt NC
J Neurosci; 2012 Apr; 32(17):6000-13. PubMed ID: 22539860
[TBL] [Abstract][Full Text] [Related]
10. Novel targets for valproic acid: up-regulation of melatonin receptors and neurotrophic factors in C6 glioma cells.
Castro LM; Gallant M; Niles LP
J Neurochem; 2005 Dec; 95(5):1227-36. PubMed ID: 16313512
[TBL] [Abstract][Full Text] [Related]
11. Expressional changes after histone deacetylase inhibition by valproic acid in LNCaP human prostate cancer cells.
Thelen P; Schweyer S; Hemmerlein B; Wuttke W; Seseke F; Ringert RH
Int J Oncol; 2004 Jan; 24(1):25-31. PubMed ID: 14654937
[TBL] [Abstract][Full Text] [Related]
12. Endothelin-1 reverses the histone deacetylase inhibitor-induced increase in glial glutamate transporter transcription without affecting histone acetylation levels.
Allritz C; Bette S; Figiel M; Engele J
Neurochem Int; 2009; 55(1-3):22-7. PubMed ID: 19428803
[TBL] [Abstract][Full Text] [Related]
13. Valproic acid induces polarization, neuronal-like differentiation of a subpopulation of C6 glioma cells and selectively regulates transgene expression.
Benítez JA; Arregui L; Cabrera G; Segovia J
Neuroscience; 2008 Oct; 156(4):911-20. PubMed ID: 18771712
[TBL] [Abstract][Full Text] [Related]
14. Glutamate transporter dysfunction associated with nerve injury-induced pain in mice.
Napier IA; Mohammadi SA; Christie MJ
J Neurophysiol; 2012 Jan; 107(2):649-57. PubMed ID: 22072505
[TBL] [Abstract][Full Text] [Related]
15. Neuronal glutamate transporter EAAT4 is expressed in astrocytes.
Hu WH; Walters WM; Xia XM; Karmally SA; Bethea JR
Glia; 2003 Oct; 44(1):13-25. PubMed ID: 12951653
[TBL] [Abstract][Full Text] [Related]
16. Histone deacetylase inhibitors promote neurosteroid-mediated cell differentiation and enhance serotonin-stimulated brain-derived neurotrophic factor gene expression in rat C6 glioma cells.
Morita K; Gotohda T; Arimochi H; Lee MS; Her S
J Neurosci Res; 2009 Aug; 87(11):2608-14. PubMed ID: 19360904
[TBL] [Abstract][Full Text] [Related]
17. Clinically relevant concentrations of valproic acid modulate melatonin MT(1) receptor, HDAC and MeCP2 mRNA expression in C6 glioma cells.
Kim B; Rincón Castro LM; Jawed S; Niles LP
Eur J Pharmacol; 2008 Jul; 589(1-3):45-8. PubMed ID: 18550052
[TBL] [Abstract][Full Text] [Related]
18. Valproic acid induces apoptosis in chronic lymphocytic leukemia cells through activation of the death receptor pathway and potentiates TRAIL response.
Lagneaux L; Gillet N; Stamatopoulos B; Delforge A; Dejeneffe M; Massy M; Meuleman N; Kentos A; Martiat P; Willems L; Bron D
Exp Hematol; 2007 Oct; 35(10):1527-37. PubMed ID: 17697742
[TBL] [Abstract][Full Text] [Related]
19. Progesterone increases the activity of glutamate transporter type 3 expressed in Xenopus oocytes.
Son I; Shin HJ; Ryu JH; Kim HK; Do SH; Zuo Z
Eur J Pharmacol; 2013 Sep; 715(1-3):414-9. PubMed ID: 23602688
[TBL] [Abstract][Full Text] [Related]
20. Riluzole attenuates excitatory amino acid transporter type 3 activity in Xenopus oocytes via protein kinase C inhibition.
Choi JS; Ryu JH; Zuo Z; Yang SM; Chang HW; Do SH
Eur J Pharmacol; 2013 Aug; 713(1-3):39-43. PubMed ID: 23680119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
